These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23681309)

  • 21. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations.
    Miranda-Vilela AL; Grisolia CK; Longo JPF; Peixoto RCA; de Almeida MC; Barbosa LCP; Roll MM; Portilho FA; Estevanato LLC; Bocca AL; Báo SN; Lacava ZGM
    J Nutr Biochem; 2014 Nov; 25(11):1161-1176. PubMed ID: 25127291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of hepatoprotector Metrop GP influence on tumor growth or antitumor action of doxorubicin].
    Abduloeva NKh; Stukov AN; Moiseenko VM
    Vopr Onkol; 2011; 57(2):213-5. PubMed ID: 21809667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
    Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP
    Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer.
    Greish K; Fateel M; Abdelghany S; Rachel N; Alimoradi H; Bakhiet M; Alsaie A
    J Drug Target; 2018 Aug; 26(7):610-615. PubMed ID: 29148852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
    Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A
    Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model.
    Kratz F; Roth T; Fichiner I; Schumacher P; Fiebig HH; Unger C
    J Drug Target; 2000; 8(5):305-18. PubMed ID: 11328658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinostatic activity of methylglyoxal and related substances in tumour-bearing mice.
    Conroy PJ
    Ciba Found Symp; 1978; (67):271-300. PubMed ID: 159813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
    Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma.
    You P; Xing F; Huo J; Wang B; Di J; Zeng S; Liu J
    Oncol Rep; 2013 Jun; 29(6):2227-36. PubMed ID: 23525555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
    Awasthi N; Schwarz MA; Schwarz RE
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.
    Tikoo K; Sane MS; Gupta C
    Toxicol Appl Pharmacol; 2011 Mar; 251(3):191-200. PubMed ID: 21194538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
    Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor effect of a water-in-oil-in-water type adriamycin emulsion on Ehrlich solid tumor-bearing mice].
    Mimaki Y; Shinozawa S; Yasuda K; Yao K; Etwo K; Fukuda T; Araki Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):467-72. PubMed ID: 7184409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
    Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
    Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.